Biotechnology News

View:

  • Comatose for 23 years Belgian feels reborn

    AP – Tue Nov 24, 6:18 pm ET  
    Belgian patient Rom Houben, seen here using a specially-adapted... AFP

    BRUSSELS - With a caretaker holding his hand, a Belgian man who was diagnosed as comatose for 23 years typed out a message Tuesday that he felt reborn after decades of loneliness and frustration. A leading bioethicist, however, expressed skepticism that the man was truly communicating on his own. Full Story »

  • Asthma Combo Seems Less Influenced by Genes

    HealthDay – Mon Nov 23, 1:38 am ET  

    THURSDAY, Nov. 19 (HealthDay News) -- People's genetic makeup has been shown to affect how they respond to asthma medications, but a new study finds that many people respond well to a particular combination treatment regardless of their genes. Full Story »

  • Measure to change U. of Neb. stem-cell rule fails

    AP – Fri Nov 20, 6:07 pm ET  
    NU Board of Regent Jim McClurg of Lincoln, left, takes notes... AP

    LINCOLN, Neb. - The University of Nebraska's governing board on Friday voted not to place tighter restrictions on embryonic stem cell research than those outlined under federal guidelines, which were expanded after President Barack Obama took office. Full Story »

  • Embryonic stem cell therapy closer to human trials

    AFP – Thu Nov 19, 1:13 pm ET  
    Stem cell cultures are held up at a lab. Embryonic stem cell... AFP/Getty Images/File

    CHICAGO (AFP) - Embryonic stem cell therapy got a step closer to the clinic Thursday after US researchers said they filed a request for government approval of human trials. Full Story »

  • Company seeks to test stem cells for blindness

    Reuters – Thu Nov 19, 10:25 am ET  

    WASHINGTON (Reuters) - Advanced Cell Technology, a small Massachusetts-based biotechnology company, said on Thursday it has asked for approval to test human embryonic stem cells in treating a rare cause of blindness. Full Story »

  • FDA to review Actelion's Zavesca for additional use

    Reuters – Thu Nov 19, 2:59 am ET  

    ZURICH (Reuters) - Actelion Ltd, Europe's largest biotech company, said on Thursday the U.S. Food and Drug Administration (FDA) would review use of its drug Zavesca to treat a rare neurodegenerative disease early next year. Full Story »

  • Gene protects brain-eaters from mad cow-type disease

    Reuters – Wed Nov 18, 6:21 pm ET  

    WASHINGTON (Reuters) - Villagers in the highlands of Papua New Guinea who ritualistically ate human brains but did not die of a brain disease called kuru have a genetic mutation that protects them, researchers said Wednesday. Full Story »

  • Biotech Soybeans Good Source of Omega-3

    HealthDay – Tue Nov 17, 11:49 pm ET  

    TUESDAY, Nov. 17 (HealthDay News) -- Oil from genetically modified soybeans boosts levels of an important omega-3 fatty acid in the body, which may reduce the risk of heart attacks, U.S. researchers say. Full Story »

  • Stem Cells May Improve Heart Bypass Results

    HealthDay – Tue Nov 17, 11:48 pm ET  

    TUESDAY, Nov. 17 (HealthDay News) -- Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair. Full Story »

  • Icelandic gene pioneer Decode files for bankruptcy

    Reuters – Tue Nov 17, 3:01 pm ET  

    WASHINGTON (Reuters) - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit. Full Story »

  • Taiwan firm enters $10 million genome contest

    AFP – Tue Nov 17, 2:19 pm ET  
    A Taiwanese group has entered the running for the 10-million-dollar... Archon X Prize for Genomics

    LOS ANGELES (AFP) - A Taiwanese group has entered the running for the 10-million-dollar Archon X Prize for Genomics competition, the biggest medical prize in history, organizers said Tuesday. Full Story »

  • Genome advances promise personalized medical treatment

    McClatchy Newspapers – Mon Nov 16, 3:48 pm ET  

    WASHINGTON — A whirlwind of activity is under way to apply the findings of the $3 billion Human Genome Project to improve health care in the United States and around the world. Full Story »

  • Lawmakers used Genentech statements: report

    Reuters – Sun Nov 15, 2:15 pm ET  

    NEW YORK (Reuters) - Lobbyists working for biotech company Genentech wrote statements for more than a dozen lawmakers in the official record of the House debate on the health care bill, The New York Times reported on Sunday, citing e-mails. Full Story »

  • Mutant genes linked to Parkinson's in some: study

    Reuters – Sun Nov 15, 1:20 pm ET  

    HONG KONG (Reuters) - People of Japanese and European descent who have mutant versions of five genes may be at higher risk of developing Parkinson's disease, two large teams of researchers have found. Full Story »

  • FDA finds bits of steel, rubber in Genzyme drugs

    AP – Fri Nov 13, 5:54 pm ET  
    FILE - In this May 28, 2008 file photo, Genzyme's Manufacturing... AP

    WASHINGTON - Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues. Full Story »

  • Welcome to the Clone Farm

    Reuters – Fri Nov 13, 7:38 am ET  
    K.C., the first animal produced by cloning from a cell taken... Reuters

    ENID, Oklahoma (Reuters) - To the untrained eye, Pollard Farms looks much like any other cattle ranch. Similar looking cows are huddled in similar looking pens. But some of the cattle here don't just resemble each other. They are literally identical -- clear down to their genes. Full Story »

  • Gene Therapy Brings New Muscle to Monkeys

    HealthDay – Thu Nov 12, 11:49 pm ET  

    THURSDAY, Nov. 12 (HealthDay News) -- Researchers are reporting that injections of genes into the leg muscles of monkeys helped the animals gain muscle size and strength without side effects. Full Story »

  • Gene therapy strengthens muscles in monkeys

    Reuters – Wed Nov 11, 2:42 pm ET  

    WASHINGTON (Reuters) - A gene therapy treatment that stops the breakdown of muscle appeared safe in monkeys and may build up muscle, too, researchers reported on Wednesday. Full Story »

Pagination

Subscribe

Add headlines to your personalized My Yahoo! page (About My Yahoo! and RSS)

More News Feeds »